Emerging Therapies in the CD-38 Market: Analyzing Future Growth Potential
The CD-38 market is entering a dynamic phase of growth, with numerous emerging therapies set to revolutionize treatment for multiple myeloma and other blood cancers. The increasing competition among CD-38 companies and a growing pipeline of innovative therapies are expected to solidify CD-